![Documents Document Submission](/images/default-source/default-album/document-review/documents.jpg?sfvrsn=d9b80dc1_1)
Rate This Document
Development and Commercialization of Combination Products Update, Regulatory Considerations in Approval of Combination Products
- Description: October 2004, by Mark Kramer, Director Office of Combination Products, FDA" (175 KB)
- Published on: Nov 16, 2023
- Rating Period:
Your rating for this document has already been submitted